Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-25 @ 3:32 AM
NCT ID:
NCT04373005
Eligibility Criteria:
Inclusion Criteria:
* Patients having an active malignancy who are planned to start therapy within 6 weeks of consent or are receiving a treatment for active malignancy.
* The patient falls under either of the following categories:
1. Asymptomatic for COVID-19 (as per daily screening at the hospital entrance).
2. Has symptoms similar to those of COVID-19 (e.g. fever or flu-like symptoms such as cough or shortness of breath) that are assessed by the overseeing Investigator as being related to disease and unrelated to COVID-19 infection.
Note: Patients who recovered from previous COVID-19 infection will be eligible.
* No contraindication to performing a NP swab and blood work.
Exclusion Criteria:
* Any patients with fever, or flu-like symptoms assessed by the Investigator to be related or potentially related to COVID-19 infection will not be eligible.
* Eastern Cooperative Oncology Group (ECOG) Performance Status of 3-4
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04373005
Study Brief:
Protocol Section:
NCT04373005